📢 𝗝𝗨𝗦𝗧 𝗜𝗡: Redwire's SpaceMD Signs SpaceX Starfall Mission for 2028 Microgravity Research - $Redwire(RDW.US) $SpaceX(SPCX.US)
👉 𝗞𝗲𝘆 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀:➤ 𝗦𝗽𝗮𝗰𝗲𝗠𝗗 signed a mission contract for 𝗦𝗽𝗮𝗰𝗲𝗫'𝘀 𝗦𝘁𝗮𝗿𝗳𝗮𝗹𝗹 spacecraft.➤ Launch is planned for 𝟮𝟬𝟮𝟴.➤ Mission will carry up to 𝟯𝟮 𝗣𝗜𝗟-𝗕𝗢𝗫 pharmaceutical research units.➤ SpaceMD plans a new 𝗣𝗜𝗟-𝗕𝗢𝗫 variant designed for Starfall.➤ Platform supports pharmaceutical and biotechnology research in microgravity.➤ 𝗙𝗶𝗳𝘁𝘆-𝗳𝗼𝘂𝗿 𝗣𝗜𝗟-𝗕𝗢𝗫 systems have flown to the ISS since November 2023.➤ Company has crystallized 𝟰𝟱 unique compounds, including insulin and cancer-targeting molecules.➤ 𝟭𝟮 additional PIL-BOX systems are scheduled for launch later this year.➤ Financial terms of the SpaceX contract were not disclosed.👉 𝗪𝗵𝘆 𝗧𝗵𝗶𝘀 𝗠𝗮𝘁𝘁𝗲𝗿𝘀:➤ Expands commercial access to microgravity pharmaceutical research.➤ Strengthens Redwire's position in the growing space biotechnology market.➤ Supports faster development of therapies through more frequent research missions.➤ Deepens collaboration between Redwire and SpaceX in commercial space infrastructure.👉 𝗘𝘅𝗽𝗲𝗿𝘁 𝗦𝘁𝗮𝘁𝗲𝗺𝗲𝗻𝘁:𝗝𝗼𝗵𝗻 𝗩𝗲𝗹𝗹𝗶𝗻𝗴𝗲𝗿, CEO of SpaceMD:"For decades, Redwire has built and operated the infrastructure that has enabled critical progress in microgravity research. Now, by combining our flight-proven microgravity payloads, such as PIL-BOX, with SpaceX's innovative transportation capabilities, we're dramatically expanding our ability to serve customers, increase research cadence, and accelerate the creation of life-changing therapies."The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments